JN1547 重组人IL-23 R

我公司致力于为客户提供高纯度、低成本的活性重组蛋白，包括重组人IL-23 R在内的各类受体、细胞因子、生长因子、转录因子、激素、酶、毒性蛋白、病毒抗原等。...

特别提示：包括重组人IL-23 R在内，本公司的所有产品仅可用于科研实验，严禁用于临床医疗及其他非科研用途！

产品名称：重组人IL-23 R
英文名称：Recombinant Human Interleukin-23 Receptor
产品货号：JN1547
产品规格：10μg|50μg|500μg|1mg

本品由我们的哺乳动物细胞表达系统制备而成，目的基因编码的Gly24-Asp353在C端带有Fc标签。

IL-23 R质量控制：＞95%(还原性SDS-PAGE)


IL-23 R制剂：冻干品

IL-23 R保存：
冻干蛋白置于-20℃以下可长期保存，室温条件下可稳定保存3周。
复溶蛋白溶液可在4～7℃保存2～7天，可分装后置于-20℃保存三个月。

IL-23 R复溶：
打开试剂管前请先离心。
复溶浓度推荐大于100 μg/ml。
冻干蛋白请溶于ddH2O。
复溶后，请根据用量分装冻存，避免反复冻融。

关于IL-23 R：
Interleukin 23 receptor (IL23R) is a type I cytokine receptor for IL23. IL23 receptor complex is comprised of two subunits, the IL12Rβ1 subunit, which is shared with several cytokines, and a subunit that is unique to IL-23. IL23, after binding to IL23R, activates memory T cells and mediates pro-inflammatory activities in part by the production of IL17 through activation of TH17 lymphocytes. IL23R is expressed on T cells, NK cells, dendritic cells, and macrophages. In fact, polymorphisms of the IL23R gene were reported to be associated with susceptibility to inflammatory diseases and autoimmune diseases such as psoriasis, multiple sclerosis, Gravess ophtalmopathy and inflammatory bowel diseases. The IL23R is known to be critically involved in the carcinogenesis of different malignant tumor.

根据您的关注的重组人IL-23 R，重组Interleukin-23 Receptor，Recombinant Human Interleukin-23 Receptor，重组人Interleukin-23 Receptor，您可能还对以下产品有需求：



名称：重组小鼠干扰素α2(IFN-α2)
货号：JN0430
规格：10μg|50μg|500μg|1mg
本品由我们的大肠杆菌表达系统制备而成，目的基因编码的Cys24-Glu190表达纯化得来。

IFNA2/IFN-alpha 2质量控制：＞95%(还原性SDS-PAGE)

IFNA2/IFN-alpha 2制剂：冻干品

IFNA2/IFN-alpha 2保存：
冻干蛋白置于-20℃以下可长期保存，室温条件下可稳定保存3周。
复溶蛋白溶液可在4～7℃保存2～7天，可分装后置于-20℃保存三个月。

IFNA2/IFN-alpha 2复溶：
打开试剂管前请先离心。
复溶浓度推荐大于100 μg/ml。
冻干蛋白请溶于ddH2O。
复溶后，请根据用量分装冻存，避免反复冻融。

关于IFNA2/IFN-alpha 2：
At least 23 different variants of Interferon-α are known. The individual proteins have molecular masses between 19-26 kD and consist of proteins with lengths of 156-166 and 172 amino acids. All IFN-α subtypes possess a common conserved sequence region between amino acid positions 115-151 while the amino-terminal ends are variable. Many IFN-α subtypes differ in their sequences at only one or two positions. Naturally occurring variants also include proteins truncated by 10 amino acids at the carboxyl-terminal end.

关注重组人IL-23 R，重组Interleukin-23 Receptor，Recombinant Human Interleukin-23 Receptor，重组人Interleukin-23 Receptor的同时，为您推荐更多您可能感兴趣的产品：


JN0257 重组人FGF7(成纤维生长因子7)(KGF) 10μg|50μg|500μg|1mg
JN0464 重组小鼠TNFRSF3 10μg|50μg|500μg|1mg
JN0467 重组人TNF-α(C端His标签) 10μg|50μg|500μg|1mg
JN1904 重组小鼠补体C5 10μg|50μg|500μg|1mg
JN1950 重组人DNA聚合酶β 10μg|50μg|500μg|1mg
JN2032 重组人LSM1 10μg|50μg|500μg|1mg
JN0526 重组人胰岛素样生长因子结合蛋白4(IGFBP-4) 10μg|50μg|500μg|1mg

如果您觉得“JN1547 重组人IL-23 R”描述资料不够齐全，请联系我们获取详细资料。(联系时请告诉我从给览网看到的，我们将给您最大优惠！)
本页链接：http://www.geilan.com/com_bjbiolab/sell/itemid-8548496.html
已经有844位访客查看了本页.